Drugs for Bladder Cancer (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 515)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Tamsulosin |
Approved, Investigational |
Phase 4 |
|
106133-20-4 |
129211 |
Synonyms:
(−)-tamsulosin
(-)-Tamsulosin
(-)-YM617
(-)-YM617|Flomax®|LY-253351|Omnic®|tamsulosin hydrochloride
(R)-(−)-tamsulosin
(R)-(-)-Tamsulosin
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulphonamide
5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulphonamide
Flomax
Harnal
HGP-0412
HIP1402
|
HIP-1402
LY-253351
OMNIC
Pradif
Tamsolusin
Tamsulon
TAMSULOSIN
Tamsulosin hydrochloride
Tamsulosina
Tamsulosina [INN-Spanish]
Tamsulosine
Tamsulosine [INN-French]
Tamsulosinum
Tamsulosinum [INN-Latin]
YM-617
|
|
2 |
|
Lornoxicam |
Approved, Investigational |
Phase 4 |
|
70374-39-9 |
5282204 54690031 |
Synonyms:
Acabel
CCRIS 8589
Chlortenoxicam
CLTX
CTX
Lorcam
LORCAM (TN)
LORNOXICAM
Lornoxicamum
lornoxicamum [inn-latin]
|
RO 13-9297
RO-139297
RO-13-9297
Safem
Taigalor
Telos
Xafon
XEFO
Xefocam
|
|
3 |
|
Lidocaine |
Approved, Vet_approved |
Phase 4 |
|
137-58-6 |
3676 |
Synonyms:
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-2ETN-2MePhAcN
a-Diethylamino-2,6-dimethylacetanilide
ALGRX 3268
ALGRX-3268
ALPHACAINE
alpha-Diethylamino-2,6-dimethylacetanilide
ANESTACON
Astrazeneca brand OF lidocaine
Dalcaine
Dentipatch
Dilocaine
EMBOLEX
IONTOCAINE
Jenapharm brand OF lidocanine hydrochloride
L-Caine
Lidocaina
Lidocaína
LIDOCAINE
Lidocaine carbonate
Lidocaine carbonate (2:1)
Lidocaine hydrocarbonate
Lidocaine hydrochloride
Lidocaine monoacetate
Lidocaine monohydrochloride
|
Lidocaine monohydrochloride, monohydrate
Lidocaine sulfate (1:1)
Lidocainum
LIDOCATON
Lidoderm
LIDOPEN
Lignocaine
LIGNOCAINE HCL
LIGNOSTAB
LMX 4
Novocol brand OF lidocaine hydrochloride
NSC-40030
Octocaine
ORAQIX
Strathmann brand OF lidocaine hydrochloride
VAGISIL
Xylesthesin
Xylocaine
Xylocaine®
Xylocitin
XYLODASE
Xyloneural
XYLOTOX
ZTLIDO
Α-diethylamino-2,6-dimethylacetanilide
|
|
4 |
|
Diclofenac |
Approved, Vet_approved |
Phase 4 |
|
15307-86-5, 15307-79-6 |
3033 |
Synonyms:
[2-(2,6-Dichloroanilino)phenyl]acetate
[2-(2,6-Dichloroanilino)phenyl]acetic acid
2-((2,6-Dichlorophenyl)amino)benzeneacetate
2-((2,6-Dichlorophenyl)amino)benzeneacetic acid
2-[(2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID
ACOFLAM
ACOFLAM RET
ACOFLAM SR
Allvoran
Apo-Diclo
ARTHRONAC
ARTHROTEC
ARTHROTEC 50
ARTHROTEC 75
Assaren
Benfofen
CAMBIA
CAT458
CATAFLAM
Cataflam®|CGP-45840B|GP-45840|Voltaren®|Voltarol®
CGP-45840B
CLOSTERIL 100
DEFANAC
DEFANAC RETARD
DEFANAC SR
Delphimix
DEXOMON RET
DEXOMON SR
Dichlofenac
Dichlofenal
Dichronic
Diclobenin
Diclofenac
Diclofenac acid
Diclofenac potassium
DICLOFENAC SOD
Diclofenac sodium
DICLOFENAC SODIUM SALT
Diclofenac, sodium
Diclofenaco
Diclofenacum
Diclofenamate
Diclofenamic acid
DICLOFLEX
DICLOFLEX RET
DICLOFLEX SR
DICLOMAX RET
DICLOMAX SR
Diclonate p
Diclophenac
Diclo-Phlogont
Diclo-Puren
Diclord
Dicloreum
DICLOTARD 100 MR
DICLOTARD 75 MR
DICLOVOL
DICLOVOL RET
DICLOVOL SR
DICLOZIP 25
DICLOZIP 50
Dicrofenac
DIFENOR XL
DIGENAC XL 100
Dolobasan
DSG318
Duravolten
DYLOJECT
Ecofenac
ECONAC
ECONAC SR
ECONAC XL
Effekton
ENSTAR SR
ENSTAR XL
ENZED
Feloran
FENACTOL
FENACTOL RET
|
FENACTOL SR
FLAMATAK MR
FLAMRASE
FLAMRASE SR
FLEXOTARD MR
GP-45840
ISCLOFEN
ISV-205
Kriplex
LOFENSAID 25
LOFENSAID 50
LOFENSAID RET 100
LOFENSAID RET 75
MASIDEMEN
MISOFEN
MOBIGEL
MOBIGEL PAINEZE
MOTIFENE
Neriodin
Novapirina
Novo-Difenac
Novo-Difenac SR
Nu-Diclo
Orthofen
Orthophen
Ortofen
PENNSAID
Primofenac
Prophenatin
ProSorb-D
RHEUMATAC RET 75
RHUMALGAN
RHUMALGAN CR 100
RHUMALGAN CR 75
RHUMALGAN SR
RHUMALGAN XL
SLOFENAC
Sodium diclofenac
Solaraze
Solaraze T
SR 38
SR-38
Tsudohmin
VALDIC 100 RET
VALDIC 75 RET
VALENAC
Valetan
VOL458
Voldal
VOLRAMAN
VOLSAID RET 100
VOLSAID RET 75
Voltaren
VOLTAREN EMULGEL
Voltaren Ophtha
VOLTAREN OPHTHALMIC
Voltaren Rapide
VOLTAREN RET
Voltaren SR
VOLTAREN XR
VOLTARENE
VOLTARENE EMULGEL
VOLTARENE L.P.
VOLTARENE RET
VOLTAREN-XR
Voltarol
VOLTAROL 12 HOUR EMULGEL P
VOLTAROL ACTIVE
VOLTAROL EMULGEL
VOLTAROL EMULGEL P
VOLTAROL GEL PATCH
VOLTAROL OPHTHA
VOLTAROL PAIN-EZE EMULGEL
VOLTAROL RET
VOLTAROL SR
Xenid
Zorvolex
ZORVOLEX CAPSULES
|
|
5 |
|
Midazolam |
Approved, Illicit |
Phase 4 |
|
59467-70-8 |
4192 |
Synonyms:
Buccolam
Buccolam®|Dormicum®|Nayzilam®|USL261 (nasal spray formulation)|Versed®
Dea no. 2884
Dormicum
Hydrochloride, midazolam
Maleate, midazolam
Mezolam
Midazolam
Midazolam base
MIDAZOLAM CIV
|
Midazolam Hcl
Midazolam hydrochloride
Midazolam maleate
Midazolamum
Midazolamum [INN-Latin]
Nayzilam
USL261
USL-261
Versed
|
|
6 |
|
Nicotine |
Approved |
Phase 4 |
|
54-11-5 |
942 89594 |
Synonyms:
(-)-3-(1-Methyl-2-pyrrolidyl)pyridine
(-)-3-(N-Methylpyrrolidino)pyridine
(−)-nicotine
(-)-Nicotine
(+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(+)-Nicotine
(+-)-Nicotine
(R)-3-(1-Methyl-2-pyrrolidinyl)pyridine
(R,S)-Nicotine
(RS)-Nicotine
(S)-(−)-nicotine
(S)-(-)-Nicotine
(S)-3-(1-Methylpyrrolidin-2-yl)pyridine
(S)-3-(N-Methylpyrrolidin-2-yl)pyridine
(S)-Nicotine
1-Methyl-2-(3-pyridal)-pyrrolidene
1-Methyl-2-(3-pyridal)-pyrrolidine
1-Methyl-2-(3-pyridiyl)pyrrolidine
1-Methyl-2-(3-pyridyl)pyrrolidine
2'-beta-H-Nicotine
3-(1-Methyl-2-pyrollidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)pyridine
3-(1-Methyl-2-pyrrolidinyl)-pyridine
3-(1-Methylpyrrolidin-2-yl)pyridine
3-(2-(N-Methylpyrrolidinyl))pyridine
3-(N-Methylpyrollidino)pyridine
3-(N-Methylpyrrolidino)pyridine
3-N-Methylpyrrolidine
a -N-Methylpyrrolidine
alpha-N-Methylpyrrolidine
a-N-Methylpyrrolidine
beta-Pyridyl-alpha-N-methylpyrrolidine
Bitartrate, nicotine
Black Leaf
Black Leaf 40
Campbell's Nico-Soap
Commit
delta-Nicotine
Destruxol
Destruxol Orchid Spray
DL-Tetrahydronicotyrine
D-Nicotine
Emo-Nik
Flux Maag
Fumeto bac
Fumetobac
Habitrol
L(−)-nicotine
L(-)-Nicotine
L-3-(1-Methyl-2-pyrrolidyl)pyridine
L-Nicotine
|
Mach-Nic
Methyl-2-pyrrolidinyl)pyridine
Niagara P.A. Dust
NICABATE
Nicocide
Nicoderm
NICODERM CQ
Nico-Dust
Nico-Fume
NICOPASS
NICOPATCH
Nicorette
NICORETTE INVISI
Nicorette Plus
Nicorette®|Nicotrol®
Nicotin
Nicotina
Nicotine
Nicotine alkaloid
Nicotine betadex
Nicotine bitartrate
Nicotine polacrilex
Nicotine tartrate
NICOTINELL CLASSIC
NICOTINELL SUPPORT
NICOTINELL TTS 10
NICOTINELL TTS 20
NICOTINELL TTS 30
NICOTROL
NICOTROL INHALER
NICOTROL NS
Nic-Sal
Nikotin
Nikotyna
NIQUITIN
NIQUITIN CLR
NIQUITIN MINIS CHERRY
NIQUITIN MINIS MINT
NIQUITIN MINIS ORANGE
NIQUITIN MINT
NIQUITIN PRE-QUIT
NIQUITIN STRIPS MINT
Ortho N-4 Dust
Ortho N-5 Dust
PROSTEP
R)-(+)-Nicotine
STOPPERS
STUBIT
Tartrate, nicotine
Tendust
|
|
7 |
|
Bupropion |
Approved |
Phase 4 |
|
31677-93-7, 34841-39-9, 34911-55-2 |
444 |
Synonyms:
(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
(+-)-Bupropion
Amfebutamona
Amfebutamone
AMFEBUTAMONE HCL
amfebutamone|BW-323|Wellbutrin®|Zyban®
Amfebutamonum
BUPROPION
BUPROPION HCL
Bupropion hydrochloride
Bupropion hydrochloride, (+-)-isomer
Bupropion, (+-)-isomer
BW-323
Esteve brand OF bupropion hydrochloride
FORFIVO XL
glaxo Wellcome brand 1 OF bupropion hydrochloride
|
glaxo Wellcome brand 2 OF bupropion hydrochloride
glaxo Wellcome brand 3 OF bupropion hydrochloride
GlaxoSmithKline brand 1 OF bupropion hydrochloride
GlaxoSmithKline brand 2 OF bupropion hydrochloride
NSC-315851
Quomen
Wellbatrin
Wellbutrin
WELLBUTRIN 100
WELLBUTRIN 75
WELLBUTRIN SR
WELLBUTRIN XL
Zyban
Zyban (anti-smoking)
Zyban (bupropion)
Zyntabac
|
|
8 |
|
Dopamine |
Approved |
Phase 4 |
|
62-31-7, 51-61-6 |
681 |
Synonyms:
2-(3,4-Dihydroxyphenyl)ethylamine
3,4 Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenylethylamine
3-Hydroxytyramine
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-AZANYLETHYL)BENZENE-1,2-DIOL
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL-279
CARBILEV
Deoxyepinephrine
Dopamin
Dopamina
DOPAMINE
DOPAMINE HCL
|
Dopamine hydrochloride
DOPAMIN-NATTERMAN
Dopaminum
Dopastat
Dophamine
DOPMIN
Dynatra
Hydrochloride, dopamine
Hydroxytyramin
Hydroxytyramine
Intropin
Medopa
NSC-169105
NSC-173182
Oxytyramine
PARCOPA
Revivan
SABAX DOPAMIN
SELECTAJET
SINEMET
|
|
9 |
|
Alverine |
Approved, Investigational |
Phase 4 |
|
150-59-4 |
3678 |
Synonyms:
Alverina
ALVERINE
Alverine citrate
Alverine hydrochloride
Alverinum
Bis(gamma-phenylpropyl)ethylamine
Bis(g-phenylpropyl)ethylamine
Bis(γ-phenylpropyl)ethylamine
Di(phenylpropyl)ethylamine
N,N-Bis(3-phenylpropyl)ethylamine
|
N-Ethyl-3,3'-diphenyldipropylamine
N-Ethyl-3-phenyl-N-(3-phenylpropyl)-1-propanamine
N-Ethyl-bis(3-phenylpropyl)amin
N-Ethyl-N-(3-phenylpropyl)benzenepropanamine
Norgine brand OF alverine citrate
Phenopropamine
Phenpropamine
Spasmaverine
Spasmonal
United drug brand OF alverine citrate
|
|
10 |
|
Mebeverine |
Approved, Investigational |
Phase 4 |
|
3625-06-7 |
4031 |
Synonyms:
4-(Ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) veratrate
4-{ethyl[1-(4-methoxyphenyl)propan-2-yl]amino}butyl 3,4-dimethoxybenzoic acid
Arluy
COLOFAC
CSAG-144
Duspatalin
|
Mebeverina
MEBEVERINE
Mebeverine hydrochloride
Mebeverinum
Spasmotalin
|
|
11 |
|
Neostigmine |
Approved, Vet_approved |
Phase 4 |
|
59-99-4 |
4456 5824 |
Synonyms:
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate
(m-Hydroxyphenyl)trimethylammonium dimethylcarbamic acid
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AMMONIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYLAZANIUM
[3-(DIMETHYLCARBAMOYLOXY)PHENYL]-TRIMETHYL-AZANIUM
[3-[DIMETHYLAMINO(OXO)METHOXY]PHENYL]-TRIMETHYLAMMONIUM
3-Trimethylammoniumphenyl N,N-dimethylcarbamate
3-Trimethylammoniumphenyl N,N-dimethylcarbamic acid
BLOXIVERZ
Bromide, neostigmine
Eustigmin
Eustigmine
Methylsulfate, neostigmine
m-Trimethylammoniumphenyldimethylcarbamate
m-Trimethylammoniumphenyldimethylcarbamic acid
Neostigmina
NEOSTIGMINE
|
Neostigmine bromide
NEOSTIGMINE METHYL SULFATE
Neostigmine methylsulfate
NEOSTIGMINE METILSULFATE
NSC-93753
Polstigmine
Proserine
Prostigmin
PROSTIGMIN (TN)
Prostigmin®
Prostigmine
Prozerin
ROBINUL-NEOSTIG
Synstigmin
Syntostigmine
Vagostigmine
|
|
12 |
|
Glycopyrronium |
Approved, Investigational, Vet_approved |
Phase 4 |
|
596-51-0, 740028-90-4 |
3494 |
Synonyms:
AD-237
AHR-504
AHR-504|Qbrexza® (glycopyrronium cloth)|Robinul®|Seebri Neohaler®|Tovanor Breezhaler®
Bromide, glycopyrronium
CHF5259
CHF-5259
CUVPOSA
Glicopirronio
Glycopyrrolate
Glycopyrrolate cation
Glycopyrrolate ion
Glycopyrrolic acid
GLYCOPYRRONE BROMIDE
GLYCOPYRRONIUM
Glycopyrronium bromide
GLYCOPYRRONIUM CATION
Glycopyrronium ion
|
GLYRX-PF
LONHALA MAGNAIR KIT
NSC-250836
NSC-251251
NSC-251252
NVA 237
NVA237
NVA-237
ORG-NC-45
PT001
PT-001
Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-, bromide
ROBINUL
ROBINUL FORTE
ROBINUL FTE
SEEBRI
SIALANAR
|
|
13 |
|
Mepivacaine |
Approved, Vet_approved |
Phase 4 |
|
96-88-8, 1722-62-9 |
4062 |
Synonyms:
(+-)-1-Methyl-2',6'-pipecoloxylidide
1-Methyl-2',6'-pipecoloxylidide
3m Brand OF mepivacaine hydrochloride
Abbott brand OF mepivacaine hydrochloride
APF-135
Arestocaine HCL
Astra brand OF mepivacaine hydrochloride
AstraZeneca brand OF mepivacaine hydrochloride
Aventis brand OF mepivacaine hydrochloride
Braun brand OF mepivicaine hydrochloride
Braun, mepivacaina
Carbocain
Carbocaine
Carbocaïne
Carboplyin dental
Clarben brand OF mepivacaine hydrochloride
Curasan brand OF mepivacaine hydrochloride
Dentsply brand OF mepivacaine hydrochloride
DL-Mepivacaine
Hexal brand OF mepivacaine hydrochloride
Hydrochloride, mepivacaine
Inibsa brand OF mepivacaine hydrochloride
Isocaine
Isocaine HCL
Isogaine
Meaverin
Mecain
Mepihexal
|
Mepivacain injektopas
Mepivacaina
Mepivacaina [INN-Spanish]
Mepivacaina braun
MEPIVACAINE
Mepivacaine HCL
Mepivacaine hydrochloride
Mepivacaine monohydrochloride
Mepivacain-injektopas
Mepivacainum
Mepivacainum [INN-Latin]
Mepivastesin
Mepivicaine
Monohydrochloride, mepivacaine
N-(2,6-Dimethylphenyl)-1-methyl-2-piperidinecarboxamide
N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
Novocol brand OF mepivacaine hydrochloride
Pascoe brand OF mepivacaine hydrochloride
Polocaine
POLOCAINE-MPF
Sanofi brand OF mepivacaine hydrochloride
Scandicain
Scandicaine
Scandicane
Scandinibsa
Scandonest
Scandonest Plain
S-Ropivacaine mesylate
|
|
14 |
|
Levoleucovorin |
Approved, Experimental, Investigational |
Phase 4 |
|
68538-85-2, 58-05-9, 73951-54-9 |
149436 6006 |
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R)-Leucovorin
(6R,2'S)-Folinic acid
(6R,S)-5-Formyltetrahydrofolate
(6S)-5-Formyl-5,6,7,8-tetrahydrofolate
(6S)-5-FORMYL-5,6,7,8-TETRAHYDROFOLIC ACID
(6S)-5-Formyltetrahydrofolate
(6S)-5-FORMYLTETRAHYDROFOLIC ACID
(6S)-Folinate
(6S)-FOLINIC ACID
(6S)-LEUCOVORIN
(S)-LEUCOVORIN
[6R]-5-formyl-5,6,7,8-tetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5 Formyltetrahydrofolate
5 Formyltetrahydropteroylglutamate
5-Formlyl-5,6,7,8-tetrahydrofolate,calcium salt
5-Formyl-(6S)-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formylTHF
6 S Leucovorin
6R-Leucovorin
6S Leucovorin
6S-Leucovorin
6-S-Leucovorin
Acid, folinic
Acide folinique
Acido folinico
ácido levofolínico
Calcium citrovorum factor
Calcium folinate
Calcium leucovorin
CF
Citrovorum factor
Dextrofolinic acid
Factor, citrovorum
Folinate
Folinate, calcium
Folinic acid
Folinic acid calcium salt
Folinic acid calcium salt USP27
Folinic acid SF
Folinic acid-SF
FUSILEV
KHAPZORY
|
Kunyrin
L(-)-5-Formyl-5,6,7,8-tetrahydrofolate
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucoverin
Leucovorin
Leucovorin calcium
Leucovorin folinic acid
Leucovorin, (D)-isomer
Leucovorin, (DL)-isomer
Leucovorin, (R)-isomer
Leucovorin, (S)-isomer
Leucovorin, calcium
Leucovorin, calcium (1:1) salt
Leucovorin, calcium (1:1) salt, (DL)-isomer
Leucovorin, calcium (1:1) salt, (S)-isomer
Leucovorin, calcium (1:1) salt, pentahydrate
Leucovorin, monopotassium salt, (S)-isomer
Leucovorin, monosodium salt
Leucovorin, monosodium salt, (S)-isomer
Leucovorinum
Leukovorin
Leukovorum
Levo leucovorin
LEVOFOLENE
Levofolinate
LEVOFOLINIC ACID
Levoleucovorin
Levo-leucovorin
L-Folinate
L-FOLINIC ACID
LFP-754
L-Leucovorin
L-N-[P-[[(2-amino-5-Formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-glutamic acid
Monosodium salt leucovorin
N(5)-Formyltetrahydrofolate
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamate
N-[4-({[(6S)-2-AMINO-5-FORMYL-4-OXO-1,4,5,6,7,8-HEXAHYDROPTERIDIN-6-YL]METHYL}AMINO)BENZOYL]-L-GLUTAMIC ACID
N-{[4-({[(6R)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)phenyl]carbonyl}-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Pteroyl-D-glutamate
Rescuvolin
S Leucovorin
S-Leucovorin
Welcovorin
Wellcovorin
|
|
15 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
16 |
|
Benzocaine |
Approved, Investigational |
Phase 4 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
17 |
|
Tannic acid |
Approved |
Phase 4 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
18 |
|
Cisatracurium |
Approved, Investigational |
Phase 4 |
|
96946-41-7 |
62887 |
Synonyms:
(1r,2r,1'r,2'r)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
(1R,2R,1'r,2'r)-Atracurium
(1R-cis,1'r-cis)-2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
(1R-cis,1'r-cis)-Atracurium
CISATRACURIUM
|
Cisatracurium besilate
Cisatracurium besylate
Cisatracurium cation
Cisatracurium ion
Nimbex
|
|
19 |
|
Remifentanil |
Approved |
Phase 4 |
|
132875-61-7 |
60815 |
Synonyms:
3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
GI 87084X
GI-87084B
IDS-NR-005
Remifentanil
|
Remifentanil hydrochloride
Remifentanil monohydrochloride
Remifentanilo
Remifentanyl
Ultiva
|
|
20 |
|
Sufentanil |
Approved, Investigational |
Phase 4 |
|
56030-54-7 |
41693 |
Synonyms:
Chronogesic
Citrate, sufentanil
Curasan brand OF sufentanil citrate
Curasan, sufentanil
Hameln brand OF sufentanil citrate
IDS-NS-001
Janssen brand OF sufentanil citrate
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
R-30730
Ratiopharm brand OF sufentanil citrate
Sufenta
Sufenta®|sufentanil citrate|Zalviso®
Sufentanil
Sufentanil citrate
|
Sufentanil curasan
Sufentanil hameln
Sufentanil ratiopharm
Sufentanil-hameln
SufentanilHameln
Sufentanilo
Sufentanil-ratiopharm
SufentanilRatiopharm
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanil Citrate
Sulfentanyl
Taylor brand OF sufentanil citrate
|
|
21 |
|
Levofloxacin |
Approved, Investigational |
Phase 4 |
|
100986-85-4 |
149096 |
Synonyms:
(-)-Ofloxacin
(2S)-7-FLUORO-2-METHYL-6-(4-METHYLPIPERAZIN-1-YL)-10-OXO-4-OXA-1-AZATRICYCLO[7.3.1.0^{5,13}]TRIDECA-5(13),6,8,11-TETRAENE-11-CARBOXYLIC ACID
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylate
(3S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylate
(S)-(-)-9-Fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzooxazine-6-carboxylic acid
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylate
(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid
(S)-Ofloxacin
Anhydrous, levofloxacin
Cravit
DR-3355
EVOXIL
FLOXACIN
Floxin
IQUIX
Levaquin
|
LEVOFLOXACIN
Levofloxacin anhydrous
LEVOFLOXACIN HEMIHYDRATE
Levofloxacin hydrate
Levofloxacine
Levofloxacino
Levofloxacinum
L-Ofloxacin
Ofloxacin
Ofloxacin S-(-)-form
OFLOXACIN S-(-)-FORM HEMIHYDRATE
Ofloxacin, (S)-isomer
OFTAQUIX
QUINSAIR
Quixin
RWJ-25213
TAVANIC
|
|
22 |
|
Ofloxacin |
Approved |
Phase 4 |
|
82419-36-1 |
4583 |
Synonyms:
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylate
8-Fluoro-3-methyl-9-(4-methyl-piperazin-1-yl)-6-oxo-2,3-dihydro-6H-1-oxa-3a-aza-phenalene-5-carboxylic acid
Akilen
Baccidal
Bactocin
Danoflox
DL-8280
Effexin
EXOCIN
Exocine
Flobacin
Flodemex
Flotavid
Flovid
Floxal
Floxil
Floxin
FLOXIN OTIC
Floxstat
Fugacin
Hoe 280
Hoe-280
Inoflox
J01MA01
Kinflocin
Kinoxacin
Liflox
Loxinter
Marfloxacin
Medofloxine
Mergexin
Novecin
Nufafloqo
Obide
Occidal
OCUFLOX
Ofcin
Oflin
Oflocee
Oflocet
|
Oflocin
Oflodal
Oflodex
Oflodura
Oflox
O-Flox
OFLOXACIN
Ofloxacin hydrochloride
Ofloxacine
Ofloxacino
Ofloxacinum
Ofloxin
OFLX
Ofus
Onexacin
Operan
Orocin
Otonil
Pharflox
Praxin
Puiritol
Qinolon
Qipro
Quinolon
Quotavil
Rilox
Sinflo
Tabrin
Taravid
Tariflox
Tarivid
TARIVID 400
TARIVID I.V.
Telbit
Tructum
Uro Tarivid
Viotisone
VISIREN
Zanocin
|
|
23 |
|
Ertapenem |
Approved, Investigational |
Phase 4 |
|
153832-46-3 |
150610 |
Synonyms:
(1R,5S,6S,8R,2's,4's)-2-(2-(3-Carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylate
(1R,5S,6S,8R,2's,4's)-2-(2-(3-Carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid
(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylate
(4R,5S,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid
|
Ertapenem
Ertapenem sodium
Invanoz
Invanz
|
|
24 |
|
Nitrofurantoin |
Approved, Vet_approved |
Phase 4 |
|
67-20-9 |
5353830 |
Synonyms:
1-((5-nitro-2-furanyl)methylene)amino-2,4-imidazolidenedione
1-((5-nitrofurfurylidene)amino)hydantoin
5-Nitrofurantoin
Alfuran
Apo-Nitrofurantoin
Benkfuran
BERKFURIN
CEDURAN
Chemiofuran
Cistofuran
Cyantin
Cystit
DANTAFUR
Fua Med
Fuamed
Furabid
Furachel
Furadantin
Furadantin Retard
Furadantina MC
Furadantine
Furadantine Mc
Furadantine-Mc
Furadantoin
Furadoin
Furadoine
Furadonin
Furadonine
Furadontin
FURALAN
Furaloid
Furan
Furanite
Furantoin
Furantoina
Furatoin
Furedan
Furina
Furobactina
Furophen T
Furophen T-Caps
Fur-Ren
GENFURA
Gerofuran
Ituran
It-Uran
IVADANTIN
Macpac
MACROBID
Macrodantin
|
Macrodantina
Macrofuran
Macrofurin
Monohydrate nitrofurantoin
N-(5-Nitrofurfurylidene)-1-aminohydantoin
Nierofu
Nifurantin
Nitoin
Nitrex
Nitrofan
Nitrofuradantin
Nitrofurantoin
Nitrofurantoin anhydrous
Nitrofurantoin macrocrystal
Nitrofurantoin macrocrystalline
Nitrofurantoin sodium salt
Nitrofurantoin, macrocrystalline
Nitrofurantoin, macrocrystals
Nitrofurantoin, monohydrate
nitrofurantoina
nitrofurantoine
nitrofurantoinum
Nitrofurantoinum anhydrous
Nitrofur-C
Novofuran
Novo-Furantoin
NSC-2107
NSC-44150
N-Toin
Orafuran
Parfuran
Phenurin
Ro-Antoin
Siraliden
Trantoin
Uerineks
Upiol
Urantoin
Urizept
Urodin
Urofuran
Urofurin
Urolisa
Urolong
Uro-Selz
Uro-Tablinen
USAF EA-2
Uvaleral
Welfurin
Zoofurin
|
|
25 |
|
Trimethoprim |
Approved, Vet_approved |
Phase 4 |
|
738-70-5 |
5578 |
Synonyms:
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine
BW-5672
BW-56-72
CO-Trimoxazole
IPRAL
LEDATRIM
MONOTRIM
NIH-204
NSC-106568
POLYTRIM
PRIMSOL
Proloprim
PROLOPRIN
|
SYRAPRIM
TCMDC-125538
TIEMPE
TMP
TRIMETHOPRIM
TRIMETHOPRIME
TRIMÉTHOPRIME
TRIMETHOPRIMUM
TRIMETOPRIMA
TRIMOGAL
TRIMOPAN
Trimpex
TRIMPEX 200
TRIPRIMIX 200
|
|
26 |
|
Sulfamethoxazole |
Approved |
Phase 4 |
|
723-46-6 |
5329 |
Synonyms:
3-(p-Aminobenzenesulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulfonamido)-5-methylisoxazole
3-(p-Aminophenylsulphonamido)-5-methylisoxazole
3-(Para-aminophenylsulphonamido)-5-methylisoxazole
3-Sulfanilamido-5-methylisoxazole
3-Sulphanilamido-5-methylisoxazole
4-Amino-N-(5-methyl-1,2-oxazol-3-yl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)-benzenesulfonamide
4-Amino-N-(5-methyl-3-isoxazolyl)benzenesulphonamide
5-Methyl-3-sulfanilamidoisoxazole
5-Methyl-3-sulfanylamidoisoxazole
5-Methyl-3-sulfonylamidoisoxazole
5-Methyl-3-sulphanil-amidoisoxazole
ACETYLSULFAMETHOXAZOLE
Apo-Sulfamethoxazole
Azo Gantanol
Azo-gantanol
Bactrim
Bactrimel
Gamazole
Gantanol
GANTANOL (TN)
GANTANOL-DS
Metoxal
N'-(5-methyl-3-isoxazole)sulfanilamide
N'-(5-methyl-3-isoxazolyl)sulfanilamide
N'-(5-methyl-3-isoxazolyl)-sulfanilamide
N'-(5-methylisoxazol-3-yl)sulphanilamide
N^1-(5-methyl-3-isoxazolyl)-sulfanilamide
N1-(5-Methyl-3-isoxazolyl)sulfanilamide
N1-(5-Methyl-3-isoxazolyl)-sulfanilamide
|
N1-(5-Methyl-3-isoxazolyl)sulphanilamide
Ndimethyl1-(5-methyl-3-isoxazolyl)-sulfanilamide
NSC-147832
Radonil
RO-42130
RO-4-2130
Septran
SIM
Simsinomin
Sinomin
SMX
SMZ
STX-608
Sulfamethalazole
Sulfamethoxazol
SULFAMETHOXAZOLE
SULFAMETHOXAZOLE SODIUM
Sulfamethoxazole(usan)
Sulfamethoxizole
Sulfamethylisoxazole
Sulfametoxazol
Sulfisomezole
Sulphamethalazole
Sulphamethoxazol
Sulphamethoxazole
Sulphamethoxazole BP 98
Sulpha-methoxizole
Sulphamethylisoxazole
Sulphisomezole
SUPHAMETHOXAZOLE
Trib
UROBAK
|
|
27 |
|
Clindamycin |
Approved, Vet_approved |
Phase 4 |
|
18323-44-9, 24729-96-2 |
29029 |
Synonyms:
7 Chloro 7 deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
ANTIROBE
Chlolincocin
Chlorlincocin
CHLORODEOXYLINCOMYCIN
CHLOROLINCOMYCIN
CLDM
Cleocin
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
CLEOCIN T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
CLINDAMYCIN
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
|
Clindamycin phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Evoclin
Hydrochloride, clindamycin
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
ResiDerm A
SOBELIN
U-21251
Zindaclin
|
|
28 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
Phase 4 |
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
29 |
|
Droperidol |
Approved, Vet_approved |
Phase 4 |
|
548-73-2 |
3168 |
Synonyms:
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone
1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridinyl}-2,3-dihydro-1H-benzo[D]imidazol-2-one
1-{1-[4-(4-fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one
Dehidrobenzperidol
Dehydrobenzperidol
DRIDOL
Droleptan
Droperidol
Dropéridol
|
Droperidolo
Droperidolum
Inapsine
Janssen brand OF droperidol
Kern brand OF droperidol
MCN-JR-4749
NSC-169874
R-4749
Taylor brand OF droperidol
|
|
30 |
|
Acetylsalicylic acid |
Approved, Vet_approved |
Phase 4 |
|
50-78-2 |
2244 |
Synonyms:
2-(ACETYLOXY)BENZOATE
2-(ACETYLOXY)benzoIC ACID
2-Acetoxybenzenecarboxylate
2-ACETOXYBENZENECARBOXYLIC ACID
2-ACETOXYBENZOATE
2-ACETOXYBENZOIC ACID
2-CARBOXYPHENYL ACETATE
8-HOUR BAYER
A.S.A.
A.S.A. Empirin
ACARD
ACENTERINE
Acesal
Acetal
ACETARD
ACETICYL
Acetilsalicilico
Acetilum acidulatum
Acetisal
ACETOL
ACETONYL
ACETOPHEN
Acetophen®|acetylsalicylic acid|Aspirin®
ACETOSAL
ACETOSALIC ACID
ACETOSALIN
Acetoxybenzoic acid
ACETYLIN
Acetylsal
ACETYLSALIC ACID
ACETYLSALICYLATE
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
ACETYLSALICYLSÄURE
ACETYONYL
ACETYSAL
ACETYSALICYLIC ACID
Acid, acetylsalicylic
Acide 2-(acetyloxy)benzoique
ACIDE 2-(ACÉTYLOXY)BENZOÏQUE
Acide acetylsalicylique
ACIDE ACÉTYLSALICYLIQUE
Acido acetilsalicilico
ÁCIDO ACETILSALICÍLICO
Acido O-acetil-benzoico
ACIDUM ACETYLSALICYLICUM
Acimetten
Acisal
ACYLPYRIN
Adiro
ALKA RAPID
Aloxiprimum
ANADIN ALL NIGHT
ANGETTES 75
ASA
Asagran
ASATARD
Ascoden-30
Aspalon
Aspec
ASPERGUM
ASPIRDROPS
ASPIRIN
Aspirina
Aspirine
Aspro
ASPRO CLR
Asteric
Azetylsalizylsaeure
AZETYLSALIZYLSÄURE
BAY1019036
BAYER EXTRA STRENGTH
Bayer Extra Strength Aspirin For Migraine Pain
BENASPIR
Bialpirina
BIALPIRINIA
Bi-prin
BUFFERIN
CAPRIN
CARDIOASPIRINA
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
DANAMEP
Decaten
Delgesic
Dispril
DISPRIN CV
|
DISPRIN DIRECT
Dolean pH 8
Duramax
DURLAZA
EASPRIN
ECM
ECOLEN
ECOTRIN
EMPIRIN
ENDOSPRIN
ENDYDOL
ENPRIN
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EQUI-PRIN
Extren
GENCARDIA
Globentyl
Globoid
Helicon
Idragin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LEVIUS
Magnecyl
MAX STRGH ASPRO CLR
MEASURIN
Micristin
MICROPIRIN EC
Neuronika
Novid
NSC-27223
NSC-406186
Nu-seals
NU-SEALS 300
NU-SEALS 600
NU-SEALS 75
Nu-seals aspirin
NU-SEALS CARDIO 75
O-(ACETYLOXY)BENZOATE
O-(ACETYLOXY)BENZOIC ACID
O-accetylsalicylic acid
O-ACETOXYBENZOATE
O-ACETOXYBENZOIC ACID
O-Acetylsalicylate
O-ACETYLSALICYLIC ACID
O-CARBOXYPHENYL ACETATE
O-Carboxyphenyl acetic acid
PAYNOCIL
PERSISTIN
PHARMACIN
Pirseal
PLATET
PLATET 300
Polopirin
POLOPIRYNA
POSTMI 300
POSTMI 75
PREMASPIN
RHEUMINTABLETTEN
RHODINE
Rhonal
Salacetin
SALCETOGEN
SALETIN
Salicylate acetate
SALICYLIC ACID ACETATE
Salicylic acid acetic acid
Salicylic acid, acetate
SALOSPIR
Solfrin
SOLPRIN
SOLPRIN ACID
SOLPYRON
Solupsan
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
TASPRIN
TEMPERAL
TOLDEX
TRIAMINICIN
Triple-sal
Vanquish
VAZALORE
Xaxa
Yasta
Zorprin
|
|
31 |
|
Folic acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
59-30-3 |
6037 |
Synonyms:
(2S)-2-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)FORMAMIDO]PENTANEDIOIC ACID
(2S)-2-[[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]-OXO-METHYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]GLUTARIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]BENZOYL]AMINO]PENTANEDIOIC ACID
(2S)-2-[[4-[(2-AMINO-4-OXO-1H-PTERIDIN-6-YL)METHYLAMINO]PHENYL]CARBONYLAMINO]PENTANEDIOIC ACID
[<sup>3</sup>H]-folic acid
Acide folique
ácido fólico
Acidum folicum
ACIFOLIC
Apo-Folic
B03BB01
b9, Vitamin
BIO SCIENCE
CYTOFOL
DOSFOLAT B ACTIV
FOLACID
FOLACIN
FOLATE
FOLBAL
FOLCIDIN
FOLDINE
FOLETTES
FOLIAMIN
FOLIC ACID
Folic acid, (D)-isomer
Folic acid, (DL)-isomer
Folic acid, calcium salt (1:1)
Folic acid, monopotassium salt
Folic acid, monosodium salt
Folic acid, potassium salt
Folic acid, sodium salt
FOLICARE
FOLICET
FOLIPAC
|
FOLSAEURE
FOLSAN
FOLSAURE
Folsäure
FOLSAV
FOLVITE
Folvron
INCAFOLIC
LEXPEC
LIVER LACTOBACILLUS CASEI FACTOR
MILLAFOL
N-(4-{[(2-AMINO-4-OXO-3,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)-L-GLUTAMIC ACID
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamate
N-[(4-{[(2-AMINO-4-OXO-1,4-DIHYDROPTERIDIN-6-YL)METHYL]AMINO}PHENYL)CARBONYL]-L-GLUTAMIC ACID
N-[4-[[(2-AMINO-3,4-DIHYDRO-4-OXO-6-PTERIDINYL)METHYL]AMINO]BENZOYL]-L-GLUTAMIC ACID
NATUR FLOW
N-Pteroyl-L-glutamate
N-PTEROYL-L-GLUTAMIC ACID
NSC-3073
PGA
PRECONCEIVE
PTEGLU
PTEROYLGLUTAMATE
PTEROYLGLUTAMIC ACID
PTEROYL-L-GLUTAMATE
PTEROYL-L-GLUTAMIC ACID
PTEROYL-L-MONOGLUTAMATE
PTEROYL-L-MONOGLUTAMIC ACID
PTEROYLMONOGLUTAMIC ACID
ROCHE
Vitamin B9
VITAMIN BC
VITAMIN BE
VITAMIN M
|
|
32 |
|
Omega 3 Fatty Acid |
|
Phase 4 |
|
|
|
33 |
|
Analgesics, Opioid |
|
Phase 4 |
|
|
|
34 |
|
Narcotics |
|
Phase 4 |
|
|
|
35 |
|
Adrenergic alpha-Antagonists |
|
Phase 4 |
|
|
|
36 |
|
Adrenergic alpha-1 Receptor Antagonists |
|
Phase 4 |
|
|
|
37 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
38 |
|
Solifenacin Succinate |
|
Phase 4 |
|
242478-38-2 |
216457 |
Synonyms:
SOLIFENACIN SUCCINATE
VESICARE
|
|
|
39 |
|
Anti-Anxiety Agents |
|
Phase 4 |
|
|
|
40 |
|
Sodium Channel Blockers |
|
Phase 4 |
|
|
|
41 |
|
Diuretics, Potassium Sparing |
|
Phase 4 |
|
|
|
42 |
|
GABA Modulators |
|
Phase 4 |
|
|
|
43 |
|
Cephalosporins |
|
Phase 4 |
|
|
|
44 |
|
Anesthetics |
|
Phase 4 |
|
|
|
45 |
|
Neuromuscular Nondepolarizing Agents |
|
Phase 4 |
|
|
|
46 |
|
Neuromuscular Blocking Agents |
|
Phase 4 |
|
|
|
47 |
|
Anesthetics, Local |
|
Phase 4 |
|
|
|
48 |
|
Cholinergic Antagonists |
|
Phase 4 |
|
|
|
49 |
|
Cholinergic Agents |
|
Phase 4 |
|
|
|
50 |
|
Psychotropic Drugs |
|
Phase 4 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 1390)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
The Effects of Sequential Mitomycin and Bacillus Calmette-Guérin Treatment Versus Bacillus Calmette-Guérin Monotherapy in Patients With High Risk Non-Muscle Invasive Bladder Cancer |
Unknown status |
NCT03790384 |
Phase 4 |
Mitomycin |
2 |
Chemoradiotherapy for Recurrent T1G3 Bladder Cancer After BCG Failure |
Unknown status |
NCT03274284 |
Phase 4 |
|
3 |
Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression |
Unknown status |
NCT02443844 |
Phase 4 |
Tamsulosin |
4 |
Solifenacin vs Levofloxacin vs Lornoxicam for Management of Intravesical Instillation of Bacillus Calmette-Guerin (BCG) Side Effects A Single Blinded Randomised Controlled Study |
Unknown status |
NCT03038321 |
Phase 4 |
sofenacin;Tavanic;Xefo |
5 |
The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy |
Unknown status |
NCT03831321 |
Phase 4 |
Diclofenac Sodium;Lubricant Gel |
6 |
Comparison of the Pathological Stage and Clinical Outcome of en Bloc Transurethral Resection by HybridKnife or Laser Versus Conventional Transurethral Resection for NMIBC: a Prospective, Single Centre, Randomized Study |
Unknown status |
NCT03221062 |
Phase 4 |
|
7 |
Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy and Bladder Substitutions: A Randomized Controlled Trial |
Unknown status |
NCT03147586 |
Phase 4 |
Bio-tech and omega-3 plus;placebo |
8 |
The Assessment of Postoperative Cognitive Dysfunction After Transurethral Resection of Bladder Tumor Under Spinal Anesthesia |
Unknown status |
NCT03029676 |
Phase 4 |
benzodiazepines;opioid |
9 |
Ultrasound-Guided Obturator Nerve Block for Transurethral Procedures - Interadductor Approach |
Unknown status |
NCT02696733 |
Phase 4 |
lidocaine 2%;0.9% Natrium Chloratum with a 2nd generation cephalosporin |
10 |
Comparation the Effect of C-LMA and I-gel in Regurgitation and Postoperative Complications |
Unknown status |
NCT01876836 |
Phase 4 |
|
11 |
In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? |
Completed |
NCT03174912 |
Phase 4 |
|
12 |
The Effect of Neuromuscular Blockade During Transurethral Resection of Bladder Cancer on Surgical Condition and Recovery Profiles : A Prospective, Randomized and Controlled Trial |
Completed |
NCT03039543 |
Phase 4 |
Rocuronium;Sugammadex |
13 |
Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. |
Completed |
NCT02001857 |
Phase 4 |
1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery. |
14 |
The Value of Immediate Post-operative Intravesical Epirubicin Instillation in Intermediate and High Risk Non Muscle Invasive Bladder Cancer (NMIBC): A Randomized Controlled Trial |
Completed |
NCT02214602 |
Phase 4 |
Epirubicin |
15 |
Enhancing Tobacco Use Treatment for African American Light Smokers |
Completed |
NCT00666978 |
Phase 4 |
bupropion hydrochloride |
16 |
Comparing the Lozenge to the Patch for Smoking Cessation |
Completed |
NCT00365508 |
Phase 4 |
nicotine lozenge;nicotine patch |
17 |
Mebeverine For Daytime And Nocturnal Incontinence and After Orthotopic W-Ileal Neobladders - Assessment Of Efficacy And Quality Of Life Effect Within 1 Year Post-Surgery: A Randomized Controlled Study |
Completed |
NCT03147599 |
Phase 4 |
Coloverin;Placebo |
18 |
A Phase IV Investigation of Sugammadex in Outpatient Urological Procedures |
Completed |
NCT03138967 |
Phase 4 |
Rocuronium;Sugammadex;Neostigmine;Glycopyrrolate |
19 |
Comparison of Obturator Nerve Blockade and Neuromuscular Blockade for the Prevention of Adductor Spasm in Patients Undergoing Transurethral Resection of Bladder Tumors. |
Completed |
NCT03063255 |
Phase 4 |
Obturator block;Neuromuscular block |
20 |
Impact of Remimazolam Tosilate for General Anesthesia on Prognosis After Bladder Cancer Surgery: a Randomized Controlled Trial |
Recruiting |
NCT04532606 |
Phase 4 |
Remimazolam;Propofol |
21 |
Does Prophylactic Antibiotic Decrease the Rate of Urinary Tract Infection After Robot Assisted Radical Cystectomy |
Recruiting |
NCT04502095 |
Phase 4 |
Clindamycin;Ertapenem;Levofloxacin;Nitrofurantoin;Trimethoprim-Sulfamethoxazole |
22 |
An Open Label, Randomized Control Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma |
Recruiting |
NCT05220124 |
Phase 4 |
Live Combined (Bifidobacterium,Lactobacillus and Enterococcus Capsules) |
23 |
Low-dose Neuroleptanalgesia Reduce the Occurrences of Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Major Surgery : a Randomized Controlled Trial |
Recruiting |
NCT05068180 |
Phase 4 |
low-dose neuroleptanalgesia;Placebo |
24 |
Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC |
Active, not recruiting |
NCT03348969 |
Phase 4 |
Mitomycin c |
25 |
A Prospective, Single Center Clinical Study to Examine the Safety and Efficacy of BCG Combined With Tislelizumab as Treatment for BCG-untreated Patients With High-grade Non-muscle-invasive Bladder Cancer |
Not yet recruiting |
NCT05580354 |
Phase 4 |
BCG combined with Tislelizumab |
26 |
A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma |
Not yet recruiting |
NCT05488353 |
Phase 4 |
Disitamab Vedotin for Injection,Penpulimab Injection |
27 |
Must Aspirin be Discontinued Prior to TURBT: a Prospective, Randomized, Non-inferiority Trial Comparing Peri-operative Aspirin Continuation Versus Discontinuation. |
Terminated |
NCT02350543 |
Phase 4 |
Aspirin |
28 |
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix |
Withdrawn |
NCT00785694 |
Phase 4 |
hexaminolevulinate |
29 |
Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) [TREATMENT] |
Unknown status |
NCT00553345 |
Phase 3 |
selenium;vitamin E |
30 |
A Study of Comparing Effects of Thulium Laser en Bloc Resection and Electrical Transurethral Resection of the Non-muscle Invasive Bladder Cancer |
Unknown status |
NCT02951078 |
Phase 3 |
|
31 |
Adjuvant Chemotherapy Following Radical Cystectomy to Treat Locally Advanced Bladder Cancer |
Unknown status |
NCT02074189 |
Phase 3 |
Gemcitabine, Cisplatin |
32 |
The Efficacy of Distilled Water vs Mitomycin C as a Single Dose Immediate Instillation After Transurethral Resection of Intermediate Risk, Recurrent Superficial Bladder Cancer |
Unknown status |
NCT00816075 |
Phase 2, Phase 3 |
distilled water |
33 |
Bladder Cancer Prognosis Programme (Incorporating SELENIB Trial) |
Unknown status |
NCT00553124 |
Phase 3 |
selenium;vitamin E |
34 |
Phase III Study Of Adjuvant Cisplatin-Gemcitabine Vs. Observation After Radical Cystectomy In High-Risk Bladder Cancer |
Unknown status |
NCT00054626 |
Phase 3 |
cisplatin;gemcitabine hydrochloride |
35 |
Study of the Efficacy of Maintenance Therapy by UFT or BCG for Superficial Bladder Cancer Against Recurrence in Urological Oncology Council of Northern Tokyo: EMBARK Study |
Unknown status |
NCT01082510 |
Phase 3 |
Bacille Calmette-Guerin;uracil-tegafur |
36 |
Treatment of Ta Bladder Cancer in High Risk of Recurrence - Fluorescence Cystoscopy With Optimized Adjuvant Mitomycin-C (FinnBladder 9) |
Unknown status |
NCT01675219 |
Phase 3 |
optimized MMC;single immediate chemotherapy instillation |
37 |
Determining the Specificity and Sensitivity of the BladderLight™ Assay as a Diagnostic and Risk Stratification Tool for Bladder Cancer |
Unknown status |
NCT03427034 |
Phase 2, Phase 3 |
|
38 |
HYMN: A Randomized Controlled Phase III Trial Comparing Hyperthermia Plus Mitomycin to a Second Course of Bacillus Calmette-Guerin or Standard Therapy in Patients With Recurrence of Non-Muscle Invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guerin Therapy |
Unknown status |
NCT01094964 |
Phase 3 |
epirubicin hydrochloride;mitomycin C |
39 |
Adjuvant Intraarterial Chemotherapy Following Surgery in Treating Patients With Locally Advanced Bladder Cancer |
Unknown status |
NCT01627197 |
Phase 3 |
|
40 |
A Phase II/III, Randomised, Two-Arm, Comparison of Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With HER1 and/or HER2 Overexpressing Locally Advanced or Metastatic Bladder Cancer [LaMB] |
Unknown status |
NCT00949455 |
Phase 2, Phase 3 |
lapatinib ditosylate |
41 |
Role of Geriatric Intervention in Treatment of Older Patients With Cancer : a Phase III Randomized Study (PREPARE) |
Unknown status |
NCT02704832 |
Phase 3 |
|
42 |
Four Cycles of Cisplatin-Based Chemotherapy in Metastatic Urothelial Carcinoma Compared to Six Cycles: Randomized Phase III Trial - FOCUS Study - |
Unknown status |
NCT03296306 |
Phase 3 |
Treatment duration of cisplatin based chemotherapy |
43 |
Phase III Randomized Study of a Single Adjunctive Instillation of Intravesical AD 32 (N-Trifluoroacetyladriamycin-14-valerate) Versus No Adjunctive Therapy Immediately Following Transurethral Resection in Patients With Multiple Superficial (Ta/T1) Bladder Tumors |
Unknown status |
NCT00003725 |
Phase 3 |
valrubicin |
44 |
Adjuvant vs. Progression-Triggered Treatment With Gemcitabine After Radical Cystectomy for Locally Advanced Transitional Cell Carcinoma of the Bladder in Patients Not Suitable for Cisplatin-Based Chemotherapy - A Phase 3 Study |
Unknown status |
NCT00146276 |
Phase 3 |
gemcitabine |
45 |
Randomized Double-Blind Controlled Phase III Trial of Hyperbaric Oxygen Therapy in Patients Suffering Long-Term Adverse Effects of Radiotherapy for Pelvic Cancer (HOT II) |
Unknown status |
NCT01087268 |
Phase 3 |
|
46 |
A Prospective Randomized Phase III Trial of Maintenance Pemetrexed Versus Observation in Patients With Recurrent or Metastatic Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy Without Disease Progression |
Unknown status |
NCT03193788 |
Phase 3 |
pemetrexed;Folic Acid;Vitamin B12 Injection;Dexamethasone |
47 |
Efficacy of Diclofenac Suppositories in Prevention of Immediate Side Effects of BCG Bladder Irrigations. A Double Blind Placebo Controlled Randomized Study |
Unknown status |
NCT01542567 |
Phase 3 |
Abitren;Placebo |
48 |
A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of GEMOX(Gemcitabine/Oxaliplatin) vs XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma |
Unknown status |
NCT01470443 |
Phase 3 |
Oxaliplatin |
49 |
Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder: A Randomized Controlled Trial |
Unknown status |
NCT04576286 |
Phase 3 |
|
50 |
A Prospective, Open-label Randomized Clinical Trial of a Single Bladder Instillation of Mitomycin C vs. Gemcitabine vs. No Additional Treatment Immediately After Transurethral Resection of Bladder Tumor (TURBT) |
Unknown status |
NCT02695771 |
Phase 3 |
Mitomycin C;Gemcitabine |
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
BCG Vaccine
Carboplatin
Cisplatin
CISPLATIN PWDR
doxorubicin hydrochloride liposome
|
Etoposide
etoposide phosphate
pembrolizumab
Thiotepa
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Bladder Cancer:
Embryonic/Adult Cultured Cells Related to Bladder Cancer:
|